Clinuvel Pharmaceuticals


Clinuvel Pharmaceuticals is a global and diversified biopharmaceutical company focused on developing and commercialising treatments for patients with genetic, metabolic, and life-threatening disorders, as well as healthcare solutions for the general population.

Industries

Employees

11-50

Links


Org chart

Philippe Wolgen
Managing Director and Chief Executive Officer
Collapse
Darren Keamy
Chief Financial Officer & Company Secretary
Antonella Colucci
Vice President, Commercial Affairs
Michael Turpin
Head of Digital Services
Dennis Wright
Chief Scientific Officer
Genevieve Tay
Vice President, Communications
Malcolm Bull
Head of Australian Operations & Investor Relations
Lachlan Hay
Director of Global Operations

Board & advisors

Willem Blijdorp
Non-executive Chairman
Brenda Shanahan
Non-executive Director
Karen Agersborg
Non-executive Director
Susan Smith
Non-executive Director
Jeffrey V. Rosenfeld
Non-executive Director